Nifty 50
- TCS₹2,34293.60 (4.16%)
- ICICI Bank₹1,422.80-20.20 (-1.40%)
- Tech Mahindra₹1,640.9055.90 (3.53%)
- Shriram Finance₹1,086.90-14.10 (-1.28%)
- Infosys₹1,14433.20 (2.99%)
- ITC₹266-3.00 (-1.12%)
- HCL Technologies₹1,316.1034.10 (2.66%)
- UltraTech Cement₹11,589-128.00 (-1.09%)
- Wipro₹180.954.55 (2.58%)
- Asian Paints₹2,608.70-22.30 (-0.85%)
- Bajaj Auto₹11,910190.00 (1.62%)
- SBI Life Insurance ₹1,761.10-12.10 (-0.68%)
- Hindalco Industries₹1,037.4013.40 (1.31%)
- Eicher Motors₹8,059-41.00 (-0.51%)
- HDFC Bank₹720.309.30 (1.31%)
- Maruti Suzuki₹13,376-64.00 (-0.48%)
- Tata Motors PV₹319.403.40 (1.08%)
- Bajaj Finserv₹2,002-9.00 (-0.45%)
- Grasim Industries₹3,29032.00 (0.98%)
- InterGlobe Aviation₹5,166-23.00 (-0.44%)
- Offerings
- Tools & Platforms
Tools & Calculators
- Open API
- Calculators
- SIP Calculator
- CAGR Calculator
- Compound Interest Calculator
- FD Calculator
- RD Calculator
- EPF Calculator
- Retirement Calculator
- HDFC SIP Calculator
- Mutual Fund Return Calculator
- Lumpsum Calculator
- Step Up SIP Calculator
- ETF SIP Calculator
- Brokerage Calculator
- Equity Margin Calculator
- SWP Calculator
- EMI Calculator
- MTF Calculator
- Margin Pledge Calculator
- Markets
Stocks
F&O
Mutual Funds
- More
Open Free Demat Account
Open Free Demat Account
Jagsonpal Pharma Performance
Price Movement
₹236.17
₹242.86
1 Year Performance
₹155.00
₹264.50
Markets Today
Historical Performance
Jagsonpal Pharma Share Price Today
As of 28-08-2026 17:49, Jagsonpal Pharmaceuticals Ltd. share price today is ₹0, with a change of ₹-236.99 (-100.00%) from the previous close of ₹236.99. The stock opened at ₹237.76 and traded between ₹236.17 and ₹242.86, with a total traded volume of 92231 shares. The company has a market capitalization of ₹1563.1 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹264.5 and ₹155, respectively.
Jagsonpal Pharmaceuticals Ltd. valuation metrics include a P/E ratio of 34.4, and book value of ₹5.40. Profitability indicators show ROE of 15.59% along with a dividend yield of 1.1%. Jagsonpal Pharmaceuticals Ltd. has reported revenue of ₹293.84 Cr and net profit of ₹45.48 Cr.
Jagsonpal Pharmaceuticals Ltd. technical indicators include Day RSI at 54.92, Day MFI at 65.75, Day ADX at 35.72. Additional indicators include Commodity Channel Index (CCI) at 65.4 and Williams %R at -44.04. Momentum indicators show Day MACD at 3.01, Day MACD Signal Line at 2.39, DayATR at 8.72. Rate of Change indicators for Jagsonpal Pharmaceuticals Ltd. include ROC125 at 36.09 and ROC21 at 2.82.
Exponential moving averages include EMA5 at ₹238.4, EMA10 at ₹236.5, EMA12 at ₹235.9, EMA20 at ₹234.1, EMA26 at ₹232.9, EMA50 at ₹228, EMA100 at ₹219.3, EMA200 at ₹213.1. Simple moving averages include SMA5 at ₹239.6, SMA10 at ₹235.2, SMA20 at ₹234.2, SMA30 at ₹231.1, SMA50 at ₹230.3, SMA100 at ₹216.9, SMA150 at ₹203, SMA200 at ₹202.3.
Support levels for Jagsonpal Pharma are placed at First Support ₹233.84, Second Support ₹230.69, Third Support ₹226.28. Resistance levels are seen at First Resistance ₹241.40, Second Resistance ₹245.81, Third Resistance ₹248.96. Jagsonpal Pharmaceuticals Ltd. shareholding pattern shows promoter holding at 69.05%, FII holding at 2.3%, DII holding at 0%, public holding at 28.04%.
Jagsonpal Pharma Fundamentals
Jagsonpal Pharma Financials
Indicator | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Total Revenue | 82.23 | 64.20 | 72.94 | 74.46 | 75.61 |
| Operating Expense | 64.99 | 53.04 | 56.68 | 58.03 | 61.40 |
| Operating Profit | 17.24 | 11.16 | 16.27 | 16.43 | 14.21 |
| Depreciation | 2.14 | 2.32 | 2.39 | 2.39 | 2.35 |
| Interest | 0.25 | 0.25 | 0.26 | 0.26 | 0.25 |
| Tax | 4.49 | 2.99 | 3.57 | 4.24 | 3.64 |
| Net Profit | 13.19 | 8.76 | 10.95 | 12.57 | 10.80 |
Jagsonpal Pharma Technicals
Jagsonpal Pharmaceuticals Ltd. EMA & SMA
₹240.86
↗ Bullish Moving Average
14
↘ Bearish Moving Average
2
Jagsonpal Pharma Support and Resistance
Resistance
Support
Technical Indicators
Jagsonpal Pharma Shareholding Pattern
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Promoter | 67.8 | 67.6 | 67.5 | 67.4 | 67.9 | 69 |
| FII | 2.1 | 2.2 | 2.1 | 2.1 | 2.4 | 2.3 |
| DII | 0 | 0 | 0.1 | 0.2 | 0.3 | 0.6 |
| Public | 30.1 | 30.1 | 30.2 | 30.3 | 29.4 | 28 |
Jagsonpal Pharma Delivery And Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 42.82 K | 73.89 K | 57.95% |
| Week | 54.33 K | 1.08 L | 50.43% |
| 1 Month | 97.7 K | 7.87 L | 12.41% |
| 6 Month | 91.71 K | 3.91 L | 23.45% |
Jagsonpal Pharma SWOT Analysis
Companies with no Debt
Benjamin Graham Value Screen
Strong Performer, Getting Expensive (DVM)
Companies with 10% increase in share price over three months, with rising net profit growth
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over 1 Month
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Effectively using its capital to generate profit - RoCE improving in last 2 years
Growth in Net Profit with increasing Profit Margin (QoQ)
Companies with Zero Promoter Pledge
Negative to Positive growth in Sales and Profit with Strong Price momentum
Stocks Outperforming their Industry Price Change in the Quarter
Jagsonpal Pharma Corporate Action
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 04 Sep, 2026 | 4 | FINAL | 04 Sep, 2026 | Equity Share |
| 12 Sep, 2025 | 2.5 | FINAL | 12 Sep, 2025 | Equity Share |
| 06 Sep, 2024 | 5 | FINAL | 06 Sep, 2024 | Equity Share |
| 21 Aug, 2023 | 5 | FINAL | 21 Aug, 2023 | Equity Share |
| 29 Oct, 2021 | 4 | INTERIM | 01 Nov, 2021 | Equity Share |
| 22 Sep, 2021 | 1 | FINAL | Equity Share | |
| 22 Sep, 2020 | 0.5 | FINAL | Equity Share | |
| 20 Sep, 2019 | 0.25 | FINAL | Equity Share | |
| 18 Sep, 2018 | 0.1 | FINAL | Equity Share | |
| 21 Sep, 2017 | 0.1 | FINAL | Equity Share |
Jagsonpal Pharma Stock Comparison
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹524.75 | ₹7.07 | ₹185.10 | ₹15.89 | ₹513.60 | ₹99.65 |
| % Change | 0.78% | 1.87% | -1.13% | 1.86% | -0.67% | N/A |
| Revenue TTM (₹ Cr) | ₹526.28 | ₹69.99 | ₹291.17 | ₹226.23 | ₹511.48 | ₹305.93 |
| Net Profit TTM (₹ Cr) | ₹20.77 | ₹-176.47 | ₹14.68 | ₹31.63 | ₹53.97 | ₹16.01 |
| PE TTM | 110.80 | -0.30 | 49.50 | 2.60 | 27.70 | 35.60 |
| 1 Year Return | 32.83 | 594 | 48.58 | 71.43 | -26.54 | 21.46 |
| ROCE | 3.56 | -56.37 | - | 17.36 | 23.87 | 0.77 |
Similar Stocks
SIGACHI
Sigachi Industries Ltd.
₹ 33.13
+1.91%
WINDLAS
Windlas Biotech Ltd.
₹ 997.00
+1.00%
VINEETLAB
Vineet Laboratories Ltd.
₹ 39.20
+0.49%
SOLARA
Solara Active Pharma Sciences Ltd.
₹ 623.00
+1.82%
ZIMLAB
Zim Laboratories Ltd.
₹ 125.50
+0.23%
MEDICO
Medico Remedies Ltd.
₹ 42.50
-1.87%
DCAL
Dishman Carbogen Amcis Ltd.
₹ 175.00
-1.25%
LASA
Lasa Supergenerics Ltd.
₹ 6.90
-1.00%
HALEOSLABS
Haleos Labs Ltd.
₹ 1495.00
-0.45%
ADVENZYMES
Advanced Enzyme Technologies Ltd.
₹ 299.65
+0.69%
BAJAJHCARE
Bajaj Healthcare Ltd.
₹ 320.10
-0.25%
ORTINGLOBE
Ortin Global Ltd.
₹ 15.20
+0.66%
BROOKS
Brooks Laboratories Ltd.
₹ 69.28
+4.99%
RPGLIFE
RPG Life Sciences Ltd.
₹ 2525.00
-1.66%
BAFNAPH
Bafna Pharmaceuticals Ltd.
₹ 291.35
+4.99%
ALPA
Alpa Laboratories Ltd.
₹ 64.30
+5.10%
SMSPHARMA
SMS Pharmaceuticals Ltd.
₹ 355.20
-2.00%
NECLIFE
Nectar Lifesciences Ltd.
₹ 12.49
-4.51%
MANGALAM
Mangalam Drugs and Organics Ltd.
₹ 32.00
-0.47%
INDOCO
Indoco Remedies Ltd.
₹ 248.00
+2.26%
INDSWFTLAB
Ind-Swift Laboratories Ltd.
₹ 361.00
+0.83%
LINCOLN
Lincoln Pharmaceuticals Ltd.
₹ 616.50
+0.41%
PANACEABIO
Panacea Biotec Ltd.
₹ 395.10
+0.47%
MEDICAMEQ
Medicamen Biotech Ltd.
₹ 249.00
+7.91%
THEMISMED
Themis Medicare Ltd.
₹ 126.40
+0.20%
FAQ's on JAGSNPHARM
What is the current share price of Jagsonpal Pharmaceuticals Ltd.?
What is the Market Capitalization of Jagsonpal Pharmaceuticals Ltd.?
What are the PE and PB ratios for Jagsonpal Pharmaceuticals Ltd.?
What is the 52-Week High and Low for Jagsonpal Pharmaceuticals Ltd.?
What is the current dividend yield for Jagsonpal Pharmaceuticals Ltd.?
Who are the major shareholders of Jagsonpal Pharmaceuticals Ltd.?
Who are the peers of Jagsonpal Pharmaceuticals Ltd. in the Pharmaceuticals & Biotechnology sector?
What is the latest dividend information for Jagsonpal Pharmaceuticals Ltd.?
What is the shareholding pattern for Jagsonpal Pharmaceuticals Ltd.?
Invest Anytime, Anywhere
By signing up I certify terms, conditions & privacy policy